Biomarker Reference · RBC / Hgb / Hct / Indices

What does the Red Blood Cell Count, Haemoglobin, Haematocrit, and Erythrocyte Indices test measure?

Q: Why is Red Blood Cell Count, Haemoglobin, Haematocrit, and Erythrocyte Indices measured?

The erythrocyte parameters provide the primary anaemia characterisation data. Haemoglobin below the sex-specific lower limit confirms anaemia with clinical urgency proportional to severity. The MCV-based morphological classification is the pivotal first branch in the anaemia diagnostic pathway: microcytic (MCV 97 fL) to B12 and folate deficiency, hypothyroidism, liver disease, and medication toxicity. RDW elevation above 15.0% — preceding MCV change by weeks in evolving iron, B12, and folate deficiency — is the earliest automated haematological signal of nutritional depletion and provides additional discrimination in the normocytic anaemia differential between single-cause anaemia (normal RDW) and mixed or early deficiency (elevated RDW).

Q: What is the reference range for Red Blood Cell Count, Haemoglobin, Haematocrit, and Erythrocyte Indices?

The standard reference range for Red Blood Cell Count, Haemoglobin, Haematocrit, and Erythrocyte Indices is RBC (M): 4.5–5.9 ×10⁶/µL; RBC (F): 3.8–5.2 ×10⁶/µL; Hgb (M): 13.2–17.1 g/dL; Hgb (F): 11.7–15.5 g/dL; Hct (M): 39.5–51.0%; Hct (F): 34.0–46.0%; MCV: 79–97 fL; MCH: 26–32 pg; MCHC: 31–35 g/dL; RDW: 11.5–15.0% # REVIEWER FLAG: Confirm Quest Diagnostics sex-specific and age-stratified reference intervals for all erythrocyte parameters — Quest's haemoglobin, haematocrit, and MCV ranges may differ from those used in other files; the above values are approximate Quest platform ranges, verify against current Quest documentation.. Reference ranges vary by laboratory and assay platform — interpret in context of the issuing laboratory's stated range.

Red Blood Cell Count, Haemoglobin, Haematocrit, and Erythrocyte Indices (RBC / Hgb / Hct / Indices) is a clinical biomarker used in comprehensive-panels assessment. Erythrocytes are the most abundant blood cell type — approximately 5 million per µL — produced by erythropoiesis in the bone marrow from erythroid progenitor cells under EPO regulation, maturing over 7 days through stages characterised by progressive haemoglobin accumulation and nuclear extrusion. It is measured in 1 laboratory test on BiomarkersLabs.com.

Reference Range: RBC (M): 4.5–5.9 ×10⁶/µL; RBC (F): 3.8–5.2 ×10⁶/µL; Hgb (M): 13.2–17.1 g/dL; Hgb (F): 11.7–15.5 g/dL; Hct (M): 39.5–51.0%; Hct (F): 34.0–46.0%; MCV: 79–97 fL; MCH: 26–32 pg; MCHC: 31–35 g/dL; RDW: 11.5–15.0% # REVIEWER FLAG: Confirm Quest Diagnostics sex-specific and age-stratified reference intervals for all erythrocyte parameters — Quest's haemoglobin, haematocrit, and MCV ranges may differ from those used in other files; the above values are approximate Quest platform ranges, verify against current Quest documentation.
Units: RBC: ×10⁶/µL, Hgb: g/dL, Hct: %, MCV: fL, MCH: pg, MCHC: g/dL, RDW: %
Measured In: 1 test
Category: —

Functional medicine optimalHgb (F): 13.0–15.5 g/dL; Hgb (M): 14.5–17.0 g/dL (functional optimal for peak oxygen transport); MCV: 85–95 fL; RDW-CV: <13.5% (lower RDW within the reference range correlates with better cardiovascular and all-cause mortality outcomes in population studies). # REVIEWER FLAG: Functional optimal ranges for erythrocyte parameters are not standardised in mainstream haematology — reviewer to confirm framing.

What is Red Blood Cell Count, Haemoglobin, Haematocrit, and Erythrocyte Indices?

Erythrocytes are the most abundant blood cell type — approximately 5 million per µL — produced by erythropoiesis in the bone marrow from erythroid progenitor cells under EPO regulation, maturing over 7 days through stages characterised by progressive haemoglobin accumulation and nuclear extrusion. The final nucleate reticulocyte stage lasts 24–48 hours in peripheral blood before fully maturing into a biconcave anucleate erythrocyte. The erythrocyte indices derive from automated light scatter and impedance measurements: MCV provides the mean single-cell volume in femtolitres; MCH the mean per-cell haemoglobin mass in picograms; MCHC the mean intracellular haemoglobin concentration in g/dL; and RDW-CV (coefficient of variation of RBC volume distribution) the percentage spread around the mean MCV — a sensitive indicator of size heterogeneity (anisocytosis) that rises early in developing deficiency states.

Why is Red Blood Cell Count, Haemoglobin, Haematocrit, and Erythrocyte Indices measured?

The erythrocyte parameters provide the primary anaemia characterisation data. Haemoglobin below the sex-specific lower limit confirms anaemia with clinical urgency proportional to severity. The MCV-based morphological classification is the pivotal first branch in the anaemia diagnostic pathway: microcytic (MCV <79 fL) directs to iron deficiency, thalassaemia trait, and sideroblastic anaemia workup; normocytic (MCV 79–97 fL) to haemolysis, anaemia of chronic disease, and bone marrow failure; macrocytic (MCV >97 fL) to B12 and folate deficiency, hypothyroidism, liver disease, and medication toxicity. RDW elevation above 15.0% — preceding MCV change by weeks in evolving iron, B12, and folate deficiency — is the earliest automated haematological signal of nutritional depletion and provides additional discrimination in the normocytic anaemia differential between single-cause anaemia (normal RDW) and mixed or early deficiency (elevated RDW).

Reference ranges

Standard reference: RBC (M): 4.5–5.9 ×10⁶/µL; RBC (F): 3.8–5.2 ×10⁶/µL; Hgb (M): 13.2–17.1 g/dL; Hgb (F): 11.7–15.5 g/dL; Hct (M): 39.5–51.0%; Hct (F): 34.0–46.0%; MCV: 79–97 fL; MCH: 26–32 pg; MCHC: 31–35 g/dL; RDW: 11.5–15.0% # REVIEWER FLAG: Confirm Quest Diagnostics sex-specific and age-stratified reference intervals for all erythrocyte parameters — Quest's haemoglobin, haematocrit, and MCV ranges may differ from those used in other files; the above values are approximate Quest platform ranges, verify against current Quest documentation.
Functional medicine optimal: Hgb (F): 13.0–15.5 g/dL; Hgb (M): 14.5–17.0 g/dL (functional optimal for peak oxygen transport); MCV: 85–95 fL; RDW-CV: <13.5% (lower RDW within the reference range correlates with better cardiovascular and all-cause mortality outcomes in population studies). # REVIEWER FLAG: Functional optimal ranges for erythrocyte parameters are not standardised in mainstream haematology — reviewer to confirm framing.
Units: RBC: ×10⁶/µL, Hgb: g/dL, Hct: %, MCV: fL, MCH: pg, MCHC: g/dL, RDW: %

Reference ranges vary by laboratory and assay platform. Interpret in context of the issuing laboratory's stated range.

Tests that measure Red Blood Cell Count, Haemoglobin, Haematocrit, and Erythrocyte Indices

1 test on BiomarkersLabs.com include this biomarker.

BML-CHP-005Comprehensive

Complete Blood Count (CBC) with Differential and Platelets

Red Blood Cell Count, Haemoglobin, Haematocrit, and Erythrocyte Indices reference range in this test: RBC (M): 4.5–5.9 ×10⁶/µL; RBC (F): 3.8–5.2 ×10⁶/µL; Hgb (M): 13.2–17.1 g/dL; Hgb (F): 11.7–15.5 g/dL; Hct (M): 39.5–51.0%; Hct (F): 34.0–46.0%; MCV: 79–97 fL; MCH: 26–32 pg; MCHC: 31–35 g/dL; RDW: 11.5–15.0% # REVIEWER FLAG: Confirm Quest Diagnostics sex-specific and age-stratified reference intervals for all erythrocyte parameters — Quest's haemoglobin, haematocrit, and MCV ranges may differ from those used in other files; the above values are approximate Quest platform ranges, verify against current Quest documentation.

Related clinical conditions

Related Biomarkers

Frequently measured alongside

White Blood Cell Count with 5-Part Automated DifferentialWBC w/ Diff1 test Platelet Count and Mean Platelet VolumePLT / MPV1 test

Order tests measuring Red Blood Cell Count, Haemoglobin, Haematocrit, and Erythrocyte Indices for your patients

Available exclusively to verified licensed healthcare practitioners. CLIA-certified laboratory results delivered to your secure portal.